Patents Assigned to DexCom, Inc.
-
Patent number: 12268497Abstract: The present embodiments provide systems and methods for, among others, tracking sensor insertion locations in a continuous analyte monitoring system. Data gathered from sensor sessions can be used in different ways, such as providing a user with a suggested rotation of insertion locations, correlating data from a given sensor session with sensor accuracy and/or sensor session length, and providing a user with a suggested next insertion location based upon past sensor accuracy and/or sensor session length at that location.Type: GrantFiled: September 19, 2023Date of Patent: April 8, 2025Assignee: Dexcom, Inc.Inventors: Katherine Yerre Koehler, Leif N. Bowman, Rian Draeger, Laura Dunn, Eli Reihman
-
Patent number: 12259351Abstract: Systems and methods are provided that address the need to frequently calibrate analyte sensors, according to implementation. In more detail, systems and methods provide a preconnected analyte sensor system that physically combines an analyte sensor to measurement electronics during the manufacturing phase of the sensor and in some cases in subsequent life phases of the sensor, so as to allow an improved recognition of sensor environment over time to improve subsequent calibration of the sensor.Type: GrantFiled: May 2, 2019Date of Patent: March 25, 2025Assignee: Dexcom, Inc.Inventors: Peter C Simpson, Ted T Lee, Jonathan M Hughes, Stephen J. Vanslyke, Matthew D. Wightlin
-
Patent number: 12251187Abstract: The present disclosure is related to a sensing device. The sensing device includes a sensor, a memory, a processor, and two radio units. A first radio unit of the two radio units is configured for bidirectional communication with an external device using a first radio communication protocol. The bidirectional communication comprises receiving configuration data from the external device via a first radio signal from the external device. The second radio unit of the two radio units is configured for unidirectional communication with the external device using a second radio communication protocol. The unidirectional communication comprises the second radio unit transmitting a second radio signal to the external device. The second radio signal communicates data including one or more measurements obtained by the sensor.Type: GrantFiled: August 25, 2022Date of Patent: March 18, 2025Assignees: Dexcom, Inc., Verily Life Sciences LLCInventors: William James Biederman, Robert Francis Wiser, Brian Otis
-
Patent number: 12246166Abstract: Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated.Type: GrantFiled: July 26, 2024Date of Patent: March 11, 2025Assignee: Dexcom, Inc.Inventors: John Michael Dobbles, Apurv Ullas Kamath, Aarthi Mahalingam, James H. Brauker
-
Patent number: 12250768Abstract: An example sensor interposer employing castellated through-vias formed in a PCB includes a planar substrate defining a plurality of castellated through-vias; a first electrical contact formed on the planar substrate and electrically coupled to a first castellated through-via; a second electrical contact formed on the planar substrate and electrically coupled to a second castellated through-via, the second castellated through-via electrically isolated from the first castellated through-via; and a guard trace formed on the planar substrate, the guard trace having a first portion formed on a first surface of the planar substrate and electrically coupling a third castellated through-via to a fourth castellated through-via, the guard trace having a second portion formed on a second surface of the planar substrate and electrically coupling the third castellated through-via to the fourth castellated through-via, the guard trace formed between the first and second electrical contacts to provide electrical isolation bType: GrantFiled: October 17, 2023Date of Patent: March 11, 2025Assignee: DexCom, Inc.Inventors: Sean Frick, Louis Jung, David Lari
-
Patent number: 12239469Abstract: Certain aspects of the present disclosure provide techniques for processing and presenting analyte data. Some example aspects may describe techniques for generating and providing a user interface view of a user's performance report for display. Some example aspects may describe techniques for providing one or more user interface views for display on one or more widgets.Type: GrantFiled: February 23, 2022Date of Patent: March 4, 2025Assignee: Dexcom, Inc.Inventors: Alexis P. Hauptman, Douglas Scott Kanter, Janna Caryn Kimel, Lee Anne Marie Mojica Mercado, Sonya Ann Sokolash, Travis Kroeker
-
Patent number: 12232841Abstract: In some example embodiments, there is provided a method, which includes sending a message to a server, wherein the message includes a request for a share code to enable another user to access, via a first computer, analyte data obtained from a host-patient associated with a receiver and/or an analyte report for the host-patient associated with the receiver; receiving, in response to the sending, the share code generated by the server, wherein the share code comprises a checksum portion, a password portion, and an identifier portion indicative of the host-patient; generating a user interface view including the share code; and displaying the user interface view including the share code, wherein the share code enables the other user to access, via the first computer, the analyte data and/or the analyte report. Related systems, methods, and articles of manufacture are also disclosed.Type: GrantFiled: April 19, 2021Date of Patent: February 25, 2025Assignee: Dexcom, Inc.Inventors: Daniel Justin Wiedeback, Shane Philip Delmore, Jeremy Crawford Sloan, Justin E. Schumacher
-
Patent number: 12237064Abstract: An integrated circuit includes circuitry to control a process. The process includes adjusting fuzzy-logic control parameters based on received and retrieved blood glucose-related data, predicting blood glucose levels based on the received blood-glucose-related data, and generating control signals to control dispensing of insulin based on the received blood glucose-related data and the fuzzy-logic control parameters. The process may include predicting blood glucose levels based on the retrieved blood glucose-related data. The process may include transitioning between a post-meal correction protocol and a fasting protocol. The process may include transitioning from a post-meal correction protocol to a fasting protocol when a fasting criteria is satisfied.Type: GrantFiled: May 25, 2022Date of Patent: February 25, 2025Assignee: Dexcom, Inc.Inventors: Robert C. Kircher, Jr., Richard S. Mauseth, Jason N. Bishop, Donald P. Matheson, Suray Bhatia, Jeff A. Bilmes
-
Patent number: 12226617Abstract: Systems and methods for integrating a continuous glucose sensor, including a receiver, a medicament delivery device, and optionally a single point glucose monitor are provided. Manual integrations provide for a physical association between the devices wherein a user (for example, patient or doctor) manually selects the amount, type, and/or time of delivery. Semi-automated integration of the devices includes integrations wherein an operable connection between the integrated components aids the user (for example, patient or doctor) in selecting, inputting, calculating, or validating the amount, type, or time of medicament delivery of glucose values, for example, by transmitting data to another component and thereby reducing the amount of user input required. Automated integration between the devices includes integrations wherein an operable connection between the integrated components provides for full control of the system without required user interaction.Type: GrantFiled: December 20, 2021Date of Patent: February 18, 2025Assignee: Dexcom, Inc.Inventors: James H. Brauker, Mark A. Tapsak, Sean T. Saint, Apurv Ullas Kamath, Paul V. Neale, Peter C. Simpson, Michael Robert Mensinger, Dubravka Markovic
-
Patent number: 12226234Abstract: Continuous Glucose Monitoring (CGM) devices provide glucose concentration measurements in the subcutaneous tissue with limited accuracy and precision. Therefore, CGM readings cannot be incorporated in a straightforward manner in outcome metrics of clinical trials e.g. aimed to assess new glycemic-regulation therapies. To define those outcome metrics, frequent Blood Glucose (BG) reference measurements are still needed, with consequent relevant difficulties in outpatient settings. Here we propose a “retrofitting” algorithm that produces a quasi continuous time BG profile by simultaneously exploiting the high accuracy of available BG references (possibly very sparsely collected) and the high temporal resolution of CGM data (usually noisy and affected by significant bias).Type: GrantFiled: March 13, 2023Date of Patent: February 18, 2025Assignee: Dexcom, Inc.Inventors: Claudio Cobelli, Simone Del Favero, Andrea Facchinetti, Giovanni Sparacino
-
Patent number: 12232280Abstract: Introduced here is an attachable unit that connects to a base unit through a snap-fitting mechanism. The attachable unit can include a top housing structure and a bottom housing structure that are ultrasonically welded together. The top housing structure can include the toe portion that is integral with remaining portions of the top housing structure, where the toe portion is configured to provide the snap-fit with the base unit.Type: GrantFiled: March 29, 2024Date of Patent: February 18, 2025Assignees: Verily Life Sciences LLC, DexCom, Inc.Inventors: Arthur Lin, Sean Frick
-
Patent number: 12220234Abstract: Analyte sensors and methods of manufacturing same are provided, including analyte sensors comprising multi-axis flexibility. For example, a multi-electrode sensor system 800 comprising two working electrodes and at least one reference/counter electrode is provided. The sensor system 800 comprises first and second elongated bodies E1, E2, each formed of a conductive core or of a core with a conductive layer deposited thereon, insulating layer 810 that separates the conductive layer 820 from the elongated body, a membrane layer deposited on top of the elongated bodies E1, E2, and working electrodes 802?, 802? formed by removing portions of the conductive layer 820 and the insulating layer 810, thereby exposing electroactive surface of the elongated bodies E1, E2.Type: GrantFiled: March 13, 2023Date of Patent: February 11, 2025Assignee: Dexcom, Inc.Inventors: Peter C Simpson, Robert Boock, Paul V Neale, Sebastian Bohm, Matthew D. Wightlin, Jack Pryor, Jason Mitchell, Jeff Jackson, Kaushik Patel, Antonio C. Llevares
-
Publication number: 20250025076Abstract: An analyte monitoring sensor configured for in vivo measurement of at least one analyte is provided, the sensor comprising a substrate having a substrate surface, an aptamer protective layer encapsulating at least a portion of the substrate surface, the aptamer protective layer permeable to the at least one analyte, one or more aptamer conjugates associated with at least a portion of the substrate surface and positioned between the aptamer protective layer and the substrate for obtaining measurements related to the at least one analyte in vivo. Methods of extending in vivo performance of the analyte monitoring sensor are also described.Type: ApplicationFiled: December 28, 2023Publication date: January 23, 2025Applicant: DexCom, Inc.Inventors: Shuyu Lin, Daiting Rong, Stacy Hunt DuVall, Wenjie Lan, Jason M. Halac, Jiong Zou, Devon M. Headen, Shanger Wang, Shane Richard Parnell, Berta Esteban Fernandez de Avila, Shannon Reuben Woodruff
-
Patent number: 12205718Abstract: Glucose prediction using machine learning (ML) and time series glucose measurements is described. Given the number of people that wear glucose monitoring devices and because some wearable glucose monitoring devices can produce measurements continuously, a platform providing such devices may have an enormous amount of data. This amount of data is practically, if not actually, impossible for humans to process and covers a robust number of state spaces unlikely to be covered without the enormous amount of data. In implementations, a glucose monitoring platform includes an ML model trained using historical time series glucose measurements of a user population. The ML model predicts upcoming glucose measurements for a particular user by receiving a time series of glucose measurements up to a time and determining the upcoming glucose measurements of the particular user for an interval subsequent to the time based on patterns learned from the historical time series glucose measurements.Type: GrantFiled: December 4, 2020Date of Patent: January 21, 2025Assignee: Dexcom, Inc.Inventors: Mark Derdzinski, Andrew Scott Parker
-
Patent number: 12201417Abstract: Various analyte sensor systems for controlling activation of analyte sensor electronics circuitry are provided. Related methods for controlling analyte sensor electronics circuitry are also provided. Various analyte sensor systems for monitoring an analyte in a host are also provided. Various circuits for controlling activation of an analyte sensor system are also provided. Analyte sensor systems utilizing a state machine having a plurality of states for collecting a plurality of digital counts and waking a controller responsive to a wake up signal are also provided. Related methods for such analyte sensor systems are also provided. Systems for controlling activation of analyte sensor electronics circuitry utilizing a magnetic sensor are further provided. One or more display device configured to display one or more analyte concentration values are also provided.Type: GrantFiled: March 7, 2022Date of Patent: January 21, 2025Assignee: Dexcom, Inc.Inventors: Jason Halac, Sebastian Bohm, Vincent Peter Crabtree, David DeRenzy, Mark S. Dervaes, Nicholas Kalfas, Zebediah L. McDaniel, Michael Levozier Moore, Todd Andrew Newhouse, Michael A. Ploof, Stephen Alan Reichert, Peter C. Simpson, Alexander Leroy Teeter, Rodolfo Garcia, Jaroslaw Piotrowiak, Thomas George O'Connell, Arlene G. Doria
-
Patent number: 12193781Abstract: The present disclosure relates to systems, devices and methods for receiving biosensor data acquired by a medical device, e.g., relating to glucose concentration values, and controlling the access and distribution of that data. In some embodiments, systems and methods are disclosed for monitoring glucose levels, displaying data relating to glucose values and metabolic health information, and controlling distribution of glucose data between applications executing on a computer, such as a smart phone. In some embodiments, systems and methods are disclosed for controlling access to medical data such as continuously monitored glucose levels, synchronizing health data relating to glucose levels between multiple applications executing on a computer, and/or encrypting data.Type: GrantFiled: March 12, 2021Date of Patent: January 14, 2025Assignee: Dexcom, Inc.Inventors: Michael Robert Mensinger, Esteban Cabrera, Jr., Eric Cohen, Nathaniel David Heintzman, Apurv Ullas Kamath, Gary A. Morris, Andrew Attila Pal, Eli Reihman, Jorge Valdes
-
Patent number: 12190010Abstract: A continuous glucose monitor for wirelessly transmitting data relating to glucose value to a plurality of displays is disclosed, as well as systems and methods for limiting the number of display devices that can connect to a continuous glucose transmitter. In addition, security, including hashing techniques and a changing application key, can be used to provide secure communications between the continuous glucose transmitter and the displays. Also provided is a continuous glucose monitor and techniques for authenticating multiple displays, providing secure data transmissions to multiple displays, and coordinating the interaction of commands and data updates between multiple displays.Type: GrantFiled: September 19, 2023Date of Patent: January 7, 2025Assignee: Dexcom, Inc.Inventors: Hari Hampapuram, Eric Cohen, Brian Christopher Smith, Jose Hector Hernandez-Rosas, Francis William Pascual, Michael Robert Mensinger, Shawn Larvenz
-
Patent number: 12186077Abstract: One example system includes a biosensor applicator having a housing defining a cavity configured to receive and physically couple to a biosensor device, and to apply the biosensor device to a wearer; an applicator coil antenna oriented around a first axis; and a biosensor device including a biosensor coil antenna; a first wireless transceiver electrically coupled to the biosensor coil antenna; a Bluetooth antenna; and a second wireless transceiver coupled to the Bluetooth antenna; wherein the biosensor device is physically coupled to the biosensor applicator and positioned at least partially within the cavity; and wherein the applicator coil antenna is configured to wirelessly receive electromagnetic (“EM”) energy from a remote coil antenna and wirelessly provide at least a first portion of the received EM energy to the biosensor coil antenna.Type: GrantFiled: August 8, 2022Date of Patent: January 7, 2025Assignees: VERILY LIFE SCIENCES LLC, DEXCOM, INC.Inventors: William Biederman, Anil Kumar Ram Rakhyani, Louis Jung, Stephen O'Driscoll
-
Patent number: 12187480Abstract: A system and method are provided for packaging and sterilizing analyte sensors. The packaging system provides a structure for securing the analyte sensors in a fixed position and fixed orientation within the package.Type: GrantFiled: March 9, 2022Date of Patent: January 7, 2025Assignee: DexCom, Inc.Inventors: Minda McDorman Grucela, Jinsong Gao
-
Patent number: D1057956Type: GrantFiled: March 1, 2021Date of Patent: January 14, 2025Assignee: DexCom, Inc.Inventors: Eric Gobrecht, Randall Scott Koplin, Kyle Neuser, Ryan Schoonmaker